HIF-1 alpha regulates IL-1 beta and IL-17 in sarcoidosis
ELIFE
Authors: Talreja, Jaya; Talwar, Harvinder; Bauerfeld, Christian; Grossman, Lawrence, I; Zhang, Kezhong; Tranchida, Paul; Samavati, Lobelia
Abstract
Sarcoidosis is a complex systemic granulomatous disease of unknown etiology characterized by the presence of activated macrophages and Th1/Th17 effector cells. Data mining of our RNA-Seq analysis of CD14(+) monocytes showed enrichment for metabolic and hypoxia inducible factor (HIF) pathways in sarcoidosis. Further investigation revealed that sarcoidosis macrophages and monocytes exhibit higher protein levels for HIF-alpha isoforms, HIF-1 beta, and their transcriptional co-activator p300 as well as glucose transporter 1 (Glut1). In situ hybridization of sarcoidosis granulomatous lung tissues showed abundance of HIF-1 alpha in the center of granulomas. The abundance of HIF isoforms was mechanistically linked to elevated IL-1 beta and IL-17 since targeted down regulation of HIF-1 alpha via short interfering RNA or a HIF-1 alpha inhibitor decreased their production. Pharmacological intervention using chloroquine, a lysosomal inhibitor, decreased lysosomal associated protein 2 (LAMP2) and HIF-1 alpha levels and modified cytokine production. These data suggest that increased activity of HIF-alpha isoforms regulate Th1/Th17 mediated inflammation in sarcoidosis.
Responses of Transgenic Melatonin-Enriched Goats on LPS Stimulation and the Proteogenomic Profiles of Their PBMCs
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Authors: Yang, Minghui; Tao, Jingli; Wu, Hao; Zhang, Lu; Yao, Yujun; Liu, Lixi; Zhu, Tianqi; Fan, Hao; Cui, Xudai; Dou, Haoran; Liu, Guoshi
Abstract
The anti-inflammatory activity of melatonin (MT) has been well documented; however, little is known regarding endogenously occurring MT in this respect, especially for large animals. In the current study, we created a MT-enriched animal model (goats) overexpressing the MT synthetase gene Aanat. The responses of these animals to lipopolysaccharide (LPS) stimulation were systematically studied. It was found that LPS treatment exacerbated the inflammatory response in wild-type (WT) goats and increased their temperature to 40 degrees C. In addition, their granulocyte counts were also significantly elevated. In contrast, these symptoms were not observed in transgenic goats with LPS treatment. The rescue study with MT injection into WT goats who were treated with LPS confirmed that the protective effects in transgenic goats against LPS were attributed to a high level of endogenously produced MT. The proteomic analysis in the peripheral blood mononuclear cells (PBMCs) isolated from the transgenic animals uncovered several potential mechanisms. MT suppressed the lysosome formation as well as its function by downregulation of the lysosome-associated genes Lysosome-associated membrane protein 2 (LAMP2), Insulin-like growth factor 2 receptor (IGF2R), and Arylsulfatase B (ARSB). A high level of MT enhanced the antioxidant capacity of these cells to reduce the cell apoptosis induced by the LPS. In addition, the results also uncovered previously unknown information that showed that MT may have protective effects on some human diseases, including tuberculosis, bladder cancer, and rheumatoid arthritis, by downregulation of these disease-associated genes. All these observations warranted further investigations.